Hematologic Malignancies Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Recruiting
  • Hematologic Malignancies
  • Gifu, Japan
  • +5 more
2021-12-02
Dec 2, 2021
M
Recruiting
  • Hematologic Malignancies
  • Hackensack, New Jersey
  • +14 more
2021-12-01
Dec 1, 2021
F
Terminated
  • Hematologic Malignancies
  • ProHema-CB
  • Untreated CB
  • Duarte, California
  • +10 more
2021-11-26
Nov 26, 2021
J
Available
  • Hematologic Malignancies
  • +2 more
  • CliniMACS CD34 Reagent System
  • Durham, North Carolina
    Duke University Medical Center
2021-11-12
Nov 12, 2021
M
Recruiting
  • Hematologic Malignancies
  • Busulfan 3.2 mg/kg/day
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-11-10
Nov 10, 2021
T
Recruiting
  • Hematologic Malignancies
  • Solid Tumor
  • Duarte, California
  • +17 more
2021-11-09
Nov 9, 2021
S
Not yet recruiting
  • Hematologic Malignancies
  • Shanghai, Shanghai, China
    Ruijin Hospital of Shanghai Jiaotong University School of Medici
2021-11-02
Nov 2, 2021
A
Recruiting
  • Hematologic Malignancies
  • Detroit, Michigan
  • +4 more
2021-10-25
Oct 25, 2021
C
Recruiting
  • Hematologic Malignancies
  • +16 more
  • A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
  • Birmingham, Alabama
  • +138 more
2021-10-22
Oct 22, 2021
J
Active, not recruiting
  • Hematologic Malignancies
  • CliniMACs
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
2021-10-21
Oct 21, 2021
A
Active, not recruiting
  • Advanced Solid Tumors
  • +2 more
  • New Haven, Connecticut
  • +18 more
2021-10-12
Oct 12, 2021
U
Recruiting
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
2021-09-27
Sep 27, 2021
U
Completed
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
2021-09-27
Sep 27, 2021
U
Completed
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
2021-09-27
Sep 27, 2021
U
Completed
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
2021-09-27
Sep 27, 2021
M
Recruiting
  • Hematologic Malignancies
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
2021-09-08
Sep 8, 2021
N
Enrolling by invitation
  • Lyphoma, B-Cell
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-09-02
    Sep 2, 2021
    N
    Enrolling by invitation
    • Pediatric Cancers
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2021-09-02
      Sep 2, 2021
      C
      Not yet recruiting
      • Locally Advanced Solid Tumor
      • +2 more
      • (no location specified)
      2021-08-25
      Aug 25, 2021
      T
      Terminated
      • Hematologic Malignancies
      • Hypoproliferative Thrombocytopenia
      • Mirasol platelets (MIR PLTs)
      • Reference platelets (REF PLTs)
      • Washington, District of Columbia
      • +9 more
      2021-07-28
      Jul 28, 2021
      A
      Completed
      • Advanced Solid Tumors
      • +3 more
      • Nashville, Tennessee
      • +1 more
      2021-07-20
      Jul 20, 2021
      A
      Recruiting
      • Hematologic Malignancies
      • Jacksonville, Florida
      • +4 more
      2021-07-08
      Jul 8, 2021
      M
      Recruiting
      • Solid Tumors
      • Hematologic Malignancies
        • Rochester, Minnesota
          Mayo Clinic
        2021-07-08
        Jul 8, 2021
        M
        Completed
        • Hematologic Malignancies
        • Minneapolis, Minnesota
          University of Minnesota Masonic Cancer Center
        2021-06-05
        Jun 5, 2021
        M
        Recruiting
        • Hematologic Malignancies
        • Haplo HCT <55 years old
        • +4 more
        • Minneapolis, Minnesota
          Masonic Cancer Center at University of Minnesota
        2021-05-21
        May 21, 2021